SCA
AGN

Southpoint Capital Advisors’s Allergan plc AGN Stock Holding History

Southpoint Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-450,000
Closed -$121M – 37
2016
Q1 		$121M Hold
450,000
– – 5.97% 6
2015
Q4 		$141M Sell
450,000
-15,000
-3% -$4.47M 6.53% 3
2015
Q3 		$126M Buy
+465,000
New +$143M 5.66% 5
2013
Q4 		– Sell
-150,000
Closed -$21.6M – 40
2013
Q3 		$21.6M Buy
+150,000
New +$20M 1.21% 21

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Southpoint Capital Advisors's AGN Position: Q2 2016 in Review

Southpoint Capital Advisors sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 450,000 shares — an estimated $121M sold.

Southpoint Capital Advisors first reported a position in AGN in Q3 2013 and held it in 4 quarters. The position peaked at $141M in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Southpoint Capital Advisors reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Southpoint Capital Advisors sold 450,000 Allergan plc shares in Q2 2016, an estimated $121M.
  • Southpoint Capital Advisors first reported a position in Allergan plc in Q3 2013 and held it in 4 quarters.
  • Southpoint Capital Advisors's Allergan plc position peaked at $141M in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Southpoint Capital Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.